streptomycin has been researched along with Disease Exacerbation in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnwal, RP; De Rosa, M; Pandey, A; Sharma, A; Singh, G; Singla, N | 1 |
| Ajami, NJ; Auchtung, TA; Banerjee, S; Berger, FG; Carson, JA; Chakraborty, P; Chanda, A; Chatzistamou, I; Chumanevich, A; Debnath, I; Depaep, S; Fayad, R; Gummadidala, PM; Kaur, K; O'Brien, JL; Omebeyinje, MH; Petrosino, JF; Saxena, A; Sougiannis, AJ | 1 |
| Castro, AG; Fraga, AG; Gama, JB; Martins, TG; Pedrosa, J; Saraiva, M; Silva, MT | 1 |
| Coburn, BA; Coombes, BK; Finlay, BB; Gomis, S; Li, Y; Mirakhur, K; Potter, AA | 1 |
| Gortner, L; Gottschling, S; Hermann, M; Klotz, M; Meyer, S; Shamdeen, MG; Struffert, T; Wüllenweber, J | 1 |
| Ge, NN; Orchik, DJ; Shea, JJ | 1 |
6 other study(ies) available for streptomycin and Disease Exacerbation
| Article | Year |
|---|---|
Tuberculosis: An Overview of the Immunogenic Response, Disease Progression, and Medicinal Chemistry Efforts in the Last Decade toward the Development of Potential Drugs for Extensively Drug-Resistant Tuberculosis Strains.
Topics: Antitubercular Agents; Ciprofloxacin; Disease Progression; Drug Carriers; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Streptomycin; Structure-Activity Relationship; Thiophenes; Toll-Like Receptors | 2021 |
Antibiotic-mediated bacteriome depletion in Apc
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Anti-Bacterial Agents; Colon; Disease Models, Animal; Disease Progression; Gastrointestinal Microbiome; Goblet Cells; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neomycin; Streptomycin; Vancomycin | 2018 |
Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
Topics: Animals; Anti-Bacterial Agents; Buruli Ulcer; Dexamethasone; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Female; Flow Cytometry; Immunity, Cellular; Immunosuppressive Agents; Inflammation; Lymphocytes; Mice; Mice, Inbred BALB C; Mycobacterium ulcerans; Rifampin; Streptomycin | 2012 |
Analysis of the contribution of Salmonella pathogenicity islands 1 and 2 to enteric disease progression using a novel bovine ileal loop model and a murine model of infectious enterocolitis.
Topics: Animals; Cattle; Cecum; Disease Models, Animal; Disease Progression; Enterocolitis; Genomic Islands; Ileum; Inflammation; Male; Mice; Mice, Inbred C57BL; Mutation; Phenotype; Salmonella Infections, Animal; Salmonella typhimurium; Streptomycin; Virulence | 2005 |
Simultaneous tuberculous meningoencephalitis in two siblings.
Topics: Albania; Antitubercular Agents; Brain; Brain Damage, Chronic; Child, Preschool; Contact Tracing; Diagnosis, Differential; Disease Progression; Drug Resistance, Bacterial; Drug Therapy, Combination; Emigration and Immigration; Fatal Outcome; Female; Follow-Up Studies; Germany; Humans; Magnetic Resonance Imaging; Male; Meningoencephalitis; Neurologic Examination; Siblings; Streptomycin; Tuberculoma; Tuberculosis, Meningeal | 2007 |
Summating potential and action potential ratio in Meniere's disease before and after treatment.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Audiometry, Evoked Response; Disease Progression; Endolymphatic Hydrops; Endolymphatic Shunt; Evoked Potentials; Female; Humans; Male; Meniere Disease; Middle Aged; Retrospective Studies; Streptomycin; Time Factors | 1998 |